BAP increased dose dependently with RSV ( R = @ , P < @ ) , resulting in a significantly greater increase in BAP in the RSV ( high ) group compared with placebo at all time-points ( week @ , @ @ % , P < @ ; week @ , @ @ % , P < @ ; week @ , @ @ % , P < @ ) .